Over the last few years, RMA (Red Marine Algae) has been very effectively marketed, and is used extensively by many of those suffering from:
 
Herpes labialis (HSV-1) - oral cold sores
Genitalia Herpes (HSV-2) - genital herpes
Vericella-Zoster Virus (VSV) - shingles
Cytomegolovirus (CMV)
Epstein Barr (EBV) - mononucleosis, Chronic Fatigue Syndrome

Dolphin Sea Vegetable Company (DSV), of Belfast, Northern Ireland, has, over the last few years, been supplying some of these US companies with processed raw material, while carrying out the research and development of the particular species to formulate a more potent material. This has now resulted in DSV introducing Phycoplex, a proprietary blend of Red Marine Algae now being made available as a natural whole food supplement.
 
In a series of independant laboratory tests conducted at a major university in Southern Ireland, Phycoplex was studied for its efficacy against viral, bacterial and other microbial pathogens, including the Herpes and Epstein-Barr viruses, and was found to be effective in these laboratory tests. Other potential biopharmaceutical properties were also tested, indicating that Phycoplex was effective in killing Candida albicans and Enterococcus faecalis.
 
Candida albicans is a yeast infection of the gut suffered by millions of people worldwide. Phycoplex has been shown to kill the yeast cell, thus destroying the yeast (no yeast cells left to re-grow). Candida albicans and Enterococcus faecalis are also known to be contributing factors in Irritable Bowel Syndrome (IBS), a condition with no known remedy. Phycoplex is the first all natural whole food supplement to show the potential of alleviating the symptoms of IBS and help bring the body back into balance. This 100% natural seaweed formula promises to become the new benchmark of quality and superior effectiveness when compared with other red marine algaes.
 
Since its inception in 1993, DSV has supplied wildcrafted red marine algae to other manufacturers and has been instrumental in the research and development of the pharmacological benefits of seaweeds and algae for various medical, pharmaceutical and health food companies world-wide. Using their technical expertise to develop seed stock, DSV has established its own natural aqua-farm for commercial purposes. It was through this venture in co-operation with a prestigious University in Northern Ireland, that DSV was inspired to research other rare species within the red marine algae family. From this research, the Phycoplex formulation was conceived.
 
DSV is continuing with further research and development into the immune system function and modulatory action of Phycoplex, through clinical trials conducted by The University of Ulster, a five star research and testing facility. These trials are taking place under grant-aided support of the European Union.
 
DSV is also seeking a marketing partnership for the UK and Europe.